Reviva Pharmaceuticals Adjusts Executive Salaries Amid Growth Reviva Pharmaceuticals has increased executive salaries, with CEO Dr. Laxminarayan Bhat now earning $565,000 annually. CFO Narayan Prabhu and VP Seema Bhat also received raises and bonuses. Stock options were granted, reflecting confidence in the company’s strategic goals. Analysts have upgraded Reviva’s stock, citing promising clinical trial results for its schizophrenia treatment.1